Eversept Partners, LP Applied Genetic Technologies Corp Transaction History

Eversept Partners, LP

  • $1.26 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019
SELL
$2.28 - $7.15 $33,060 - $103,675
-14,500 Closed
0 $0
Q3 2018

Nov 08, 2023
BUY
$3.85 - $7.35 $55,825 - $106,575
14,500 New
14,500 $105,000
Q3 2018

Nov 14, 2018
BUY
$3.85 - $7.35 $55,825 - $106,575
14,500 New
14,500 $106,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email